№ files_lp_3_process_7_059780
File format: docx
Character count: 1185
File size: 52 KB
Year:
2025
Region / City:
Not specified
Topic:
Medical procedures, Excluded services
Document Type:
Guideline
Author:
Not specified
Target Audience:
Healthcare providers, medical practitioners
Effective Period:
From 1/1/2025
Approval Date:
Not specified
Revision Date:
Not specified
Context:
This document provides an update on the status of capsule endoscopy for gastrointestinal tract imaging under Excluded Services Guidelines, highlighting its exclusion due to limited evidence of effectiveness and the existence of cost-effective alternatives.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
4.2.0.1
Protocol Posting Date:
June 2022
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
For accreditation purposes:
Surgical resection, including esophagectomy and esophagogastrectomy; Epithelial tumors of the esophagus, and esophagogastric junction with tumor involvement of no more than 2 cm into the proximal stomach.
Authors:
Lawrence J. Burgart, MD; William V. Chopp, MD; Dhanpat Jain, MD
Synoptic Reporting:
Core and conditional data elements must be reported in a synoptic format for accreditation.
Case Summary:
Esophagus
Histologic Type:
Adenocarcinoma, Squamous cell carcinoma, Neuroendocrine carcinoma, among others.
Year:
2021
Region / City:
Delhi, India
Subject:
Medical Research, Gastroenterology
Document Type:
Research Article
Organization / Institution:
Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Postgraduate Institute of Medical Education and Research
Authors:
Gupta N, Yelamanchi R, Agrawal H, Agarwal N
Target Audience:
Medical Researchers, Endoscopists, Healthcare Professionals
Period of Validity:
N/A
Approval Date:
May 9, 2021
Date of Revisions:
May 20, 2021
Acceptance Date:
July 19, 2021
Publication Date:
August 28, 2021
Year of diagnosis:
Prior to 2015–2019
Number of patients:
147
Sex distribution:
109 male, 38 female
Age distribution:
≤60 years: 73, >60 years: 74
Alcohol abuse:
Yes: 71, No: 76
Tobacco abuse:
Yes: 97, No: 50
Smoking index:
≤400: 93, >400: 54
BMI distribution:
<25: 108, 25–29.9: 39
Family history of cancer:
Yes: 32, No: 115
Treatment modality:
Surgery alone: 48, Surgery with adjuvant therapy: 99
Tumor location:
Upper: 17, Middle: 111, Lower: 19
Tumor length:
<5 cm: 89, ≥5 cm: 58
Macroscopic tumor type:
Superficial: 22, Protruded: 11, Medullary: 48, Mushroom: 36, Ulcerative: 19, Intracavity: 11
Histological components:
Pure small cell: 116, Mixed small cell: 31
T stage:
T1: 45, T2: 39, T3: 59, T4: 4
N stage:
N0: 50, N1: 53, N2: 32, N3: 12
TNM stage:
I: 29, II: 49, III: 69
PD-L1 expression in tumor cells (TCs):
<1%: 147, ≥1%: 0
PD-L1 expression in tumor-infiltrating immune cells (TIICs):
<1%: 82, ≥1%: 65
PD-L1 expression by CPS:
<1: 105, ≥1: 42
CD8 density/mm²:
Median 111.1, Range 7.5–1458.6
Abbreviations:
BMI: body mass index; TCs: tumor cells; TIICs: tumor-infiltrating immune cells; CPS: combined positive score
Year:
2019
Region / City:
United States
Topic:
Market Research for Endoscopy Information Systems (EIS)
Document Type:
Sources Sought Notice
Organ / Institution:
Veterans Health Administration (VHA)
Author:
Charles W. Herring
Target Audience:
Potential vendors for Endoscopy Information Systems
Period of Validity:
N/A
Approval Date:
09-25-2019
Amendment Date:
N/A
Year:
2018
Region / City:
UK
Topic:
Endoscopy services, Accreditation, National Endoscopy Database
Document Type:
Briefing
Organ / Institution:
JAG
Author:
N/A
Target Audience:
UK endoscopy services
Period of Validity:
N/A
Approval Date:
January 2018
Review Date:
January 2019
Standards Relevant:
NA
Year:
2017
Region / city:
Poole
Theme:
Endoscopy Procedures and Operational Guidelines
Document Type:
Policy
Organization:
Poole Hospital Foundation Trust
Author:
XX/XX
Target Audience:
Endoscopy Users Group
Approval Date:
March 2017
Review Date:
March 2019
Year:
2018
Region / city:
Denver, CO
Theme:
Endoscopy Equipment Installation
Document Type:
Statement of Work
Organization / Institution:
Rocky Mountain Regional VA Medical Center
Author:
Not specified
Target audience:
Contractors, Medical Equipment Installers
Period of validity:
Not specified
Approval Date:
5/7/2018
Date of changes:
Not specified
Year:
2018
Region / City:
Barcelona, Spain
Topic:
Endoscopic mucosal resection, Colonoscopy, Narrow band imaging
Document Type:
Research article
Organization / Institution:
Hospital del Mar, Barcelona
Author:
Fausto Riu Pons, Montserrat Andreu, Javier Gimeno Beltran, Marco Antonio Álvarez-Gonzalez, Agustín Seoane Urgorri, Josep Maria Dedeu, Luis Barranco Priego, Xavier Bessa
Target Audience:
Medical professionals, Gastroenterologists
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2027–2028
Location:
Seattle, WA, USA
Institution:
Virginia Mason Franciscan Health
Program:
Advanced Endoscopy Fellowship
Director:
Shayan Irani, MD
Medical Director:
Michal Hubka, MD
Founding Executive Director:
Richard A. Kozarek, MD
Application Deadline:
February 20, 2026
Submission Method:
Email or postal mail
Required Documents:
Personal data, postgraduate training, three letters of reference
Eligibility:
No J1 or H-1B visa holders; no revoked or restricted medical licenses
Year:
2026
Location:
Pomona, NY, USA
Document Type:
Medical Instruction
Institution:
Digestive Disease Associates of Rockland, PC
Author:
Medical Staff
Target Audience:
Patients scheduled for capsule endoscopy
Procedure Duration:
6-8 hours
Preparation Requirements:
Clear liquid diet, bowel cleansing with Miralax, medication adjustments for diabetes and heart conditions
Special Considerations:
Patients with pacemakers or implanted defibrillators, diabetic medication adjustments, GLP-1 medication pause
Contact Information:
845-354-3700
Website:
www.ddar.com
PPNO List Serv Query Summary: Endoscopy Suite Anesthesia and Sedation Practices — September 28, 2020
Year:
2020
Date of Summary:
September 28, 2020
Topic:
Endoscopy suite anesthesia and sedation practices
Document Type:
Query summary and response compilation
Organization:
PPNO List Serv
Region:
Ontario, Canada
Institutions Mentioned:
Muskoka Algonquin Healthcare; BCH System; Pembroke Regional Hospital
Contributors:
Amy Gargal; Angela Burke; Susan Bow
Professional Roles:
Clinical Nurse Educator; Registered Nurses; Endoscopists; Anesthetists
Keywords:
endoscopy; anesthesia; sedation; RN sedation; staffing model; endoscopy suite
Care Setting:
Hospital endoscopy units
Clinical Medications Mentioned:
Versed; Fentanyl; Midazolam; Propofol
Safety Considerations:
Infection control staffing separation (clean and dirty nurse)
Response Collection Method:
Email responses compiled into summary table
Response Waiting Period:
3 weeks before final submission
Year:
2024
Institution:
Alder Hey Children’s NHS Foundation Trust
Location:
Liverpool, UK
Document type:
Patient information leaflet
Target audience:
Patients, parents and carers
Procedure:
Upper gastrointestinal endoscopy (OGD/gastroscopy)
Anesthesia:
General anesthesia
Preparation instructions:
Fasting times for food and liquids
Risks:
Tooth or lip injury, temporary sore throat, abdominal pain, bleeding, perforation
Follow-up:
Biopsy results available in 3–4 weeks
Contact:
Gastroenterology PCO, Alder Hey Children’s NHS Foundation Trust